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Abstract
Background: Hypoventilation produces or worsens respiratory acidosis in patients with hypercapnia due to acute
exacerbations of chronic obstructive pulmonary disease (AECOPD). In these patients acid–base and hydroelectrolite
balance are closely related. Aim of the present study was to evaluate acid–base and hydroelectrolite alterations in
these subjects and the effect of non-invasive ventilation and pharmacological treatment.
Methods: We retrospectively analysed 110 patients consecutively admitted to the Internal Medicine ward of Cava
de’ Tirreni Hospital for acute exacerbation of hypercapnic chronic obstructive pulmonary disease. On admission all
patients received oxygen with a Venturi mask to maintain arterial oxygen saturation at least >90 %, and received
appropriate pharmacological treatment. Non-Invasive Ventilation (NIV) was started when, despite optimal therapy,
patients had severe dyspnea, increased work of breathing and respiratory acidosis. Based on Arterial Blood Gas
(ABG) data, we divided the 110 patients in 3 groups: A = 51 patients with compensated respiratory acidosis; B = 36
patients with respiratory acidosis + metabolic alkalosis; and C = 23 patients with respiratory acidosis + metabolic
acidosis. 55 patients received only conventional therapy and 55 had conventional therapy plus NIV.
Results: The use of NIV support was lower in the patients belonging to group B than in those belonging to group
A and C (25 %, vs 47 % and 96 % respectively; p < 0.01). A statistically significant association was found between
pCO2 values and serum chloride concentrations both in the entire cohort and in the three separate groups.
Conclusions: Our study shows that in hypercapnic respiratory acidosis due to AECOPD, differently from previous
studies, the metabolic alkalosis is not a negative prognostic factor neither determines greater NIV support need,
whereas the metabolic acidosis in addition to respiratory acidosis is an unfavourable element, since it determines
an increased need of NIV and invasive mechanical ventilation support.
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Background
Hypercapnic respiratory failure is a complex clinical and
functional condition, characterized by an alteration of
the acid/base (AB) balance, associated with multi-organ
impaired function. Several physiological systems are
involved in the control of the AB balance, namely the re-
spiratory system, the kidney, as well as red blood cells and
blood proteins, and the bicarbonate buffering system. The
AB balance and hydro-electrolytic (HE) balance are closely
related, as for any increase in CO2 (respiratory acidaemia),
a counterbalancing metabolic alkalosis occurs as main
compensatory mechanism achieved by a complex ion
urinary excretion mechanism [1].
Therefore, in order to manage the AB disorders it is
necessary to understand its fine regulatory mechanisms.
For the interpretation of AB disorders two approaches
can be used: a physical-chemical approach (which relies
on the theory of the Strong Ion Difference [SID]) or a
pathophysiologic approach (which relies on the compen-
sation laws). Many authors consider the physicochemical
approach a complex and unfeasible approach, and poorly
matching with the clinical reality. Moreover, it requires
many factors to calculate the SID. On the other hand,
the physio-pathological approach is easier and much
more reliable, because it provides a quantitative meas-
urement of the AB compensatory responses. Many trials,
performed in different clinical disorders, have supported
its use in humans [2].
In this study we used the pathophysiologic approach,
according to the compensation laws, to evaluate the
Chronic Obstructive Pulmonary Disease (COPD) acute
exacerbations.
In hypercapnic AECOPD the hypoventilation produces
or worsens respiratory acidosis. Since most of these pa-
tients, especially if elderly and critical, are multi-drugs
recipients for comorbidities, the AB and HE disorders
are very common, producing a potential bias in the in-
terpretation of the final values [3].
Thus, we sought to evaluate: 1) the AB and HE disor-
ders in hypercapnic AECOPD patients; and 2) the effect
of the type of treatment (pharmacological or by non-
invasive ventilation [NIV]) on the AB and HE disorders,
Methods
We retrospectively analysed the data of inpatients admit-
ted in 2012 to the Internal Medicine Division of Cava
de’ Tirreni Hospital (Italy) for hypercapnic AECOPD.
COPD and AECOPD were defined according to the
GOLD guidelines [4]. Hypercapnia was defined as PaCO2 >
45 mmHg [4].
Between January and December 2012, 140 patients
were admitted for hypercapnic AECOPD. Thirty patients
were excluded for the following reasons: 10 patients
were on NIV home care, 7 had a pneumonia, 3 had
ARDS, 10 had severe respiratory failure (pH < 7.1, hyper-
capnic coma or hemodynamic instability) and were ad-
mitted to the Intensive Care Unit (ICU). Information
about comorbidities were obtained from the primary
care physicians.
Anthropometric characteristics, clinical parameters,
haematological and biochemical exams, and blood gas
analyses were assessed upon admission. The Glasgow
Coma Scale was used for the state of consciousness [5].
Patients were classified into three categories: A = com-
pensated respiratory acidosis; B = respiratory acidosis
with metabolic alkalosis; and C = respiratory acidosis
with metabolic acidosis [6].
On admission all patients received oxygen with a Ven-
turi mask to maintain arterial oxygen saturation (SaO2)
at least >90 %, and received treatment, besides the treat-
ments for the comorbidities, with conventional therapy:
nebulized bronchodilators, systemic glucocorticoids, and
antibiotics [7].
NIV was started when the oxygen therapy and optimal
pharmacological treatment did not produce any clinical
improvement and patients had severe dyspnea, increased
work of breathing and respiratory acidosis (pH <7.35 or
arterial carbon dioxide pressure > 45 mmHg or both).
All patients were conscious and able to protect their air-
way and deal with respiratory secretions.
NIV was performed through oronasal mask with a
pressure/volume ventilator (Carat II, Hoffrichter). Sup-
port pressure, Positive End Expiratory Pressure (PEEP)
and triggered flows were adjusted to obtain a tidal vol-
ume of 6–8 ml/kg, the best possible oxygenation, and a
decrease in respiratory rate. Support pressure and PEEP
were modified based on the arterial gases. The mean In-
spiratory Positive Assisted Pressure (IPAP) was 16 ± 4
cmH2O. None of the patients refused the treatment or
required discontinuation of ventilation for discomfort, NIV
was suspended when clinical steady-state was achieved:
respiratory rate <24/min, heart rate <110/beats-min,
pH >7.35 and SaO2 > 90 % with FiO2 < 40 % [8].
Patients were transferred to ICU for invasive mechan-
ical ventilation if the following conditions occurred: 1)
worsening of arterial pH and PaCO2; 2) clinical signs of
pre-coma; 3) cardiovascular instability [9].
Based on ABG data, according to the compensation
laws, we divided the 110 patients in the 3 groups previ-
ously identified: A = 51 patients. with compensated re-
spiratory acidosis; B = 36 patients with respiratory
acidosis + metabolic alkalosis; and C = 23 patients. with
respiratory acidosis + metabolic acidosis.
Statistical analysis
All quantitative variables are reported as mean ± stand-
ard deviation (SD).
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Statistical analyses were conducted using parametric
or nonparametric tests, based on the continuous or
asymmetrical distribution of the variables. Student’s T
test for unpaired data was used to compare the quantita-
tive variables between the two groups: patients in NIV
support (NIV+) vs patients treated with conventional
therapy (NIV-). The χ2 test was used to compare ordinal
variables.
The odds ratio (OR) for NIV+ vs NIV- and the 95 %
confidence interval (95 % CI) were calculated using a
logistic regression analysis for the 3 categories of ABG
disorders, and group B (respiratory acidosis + metabolic
alkalosis), which showed the lower percentage of NIV
support, was used as reference group.
Linear regression analysis was used to evaluate the as-
sociation between pCO2 and blood electrolytes.
The statistical analysis was performed using Statistical
Package for Social Science (SPSS 12).
Results
The patients with COPD and hypercapnia had the fol-
lowing comorbidites: chronic ischaemic heart disease
(35 %); atrial fibrillation (15 %); heart failure (32 %); pre-
vious stroke (11 %); diabetes mellitus (26 %); chronic
renal failure (44 %). Twenty-eight percent of patients
had peripheral edema.
The vast majority of patients was receiving cardiovascu-
lar therapy: diuretics (86 %), potassium-sparing diuretics
(6 %), ACE inhibitors (25 %), angiotensin receptor antago-
nists (29 %), digoxin (9 %), selective beta blockers (6 %),
calcium channel blockers (21 %), nitro-derivatives (10 %),
as well as antidiabetic medications, aspirin, statins and in-
haled bronchodilators.
Fifty-five subjects required NIV. In 33 patients out of
the 55, the acidosis was corrected by the NIV, whereas
the remaining 22, in which the acidosis persisted, were
transferred to ICU. The mean NIV time, in successfully
treated patients, was 7.8 ± 5.0 days.
NIV+ vs NIV-
Anthropometric data, clinical, biochemical and ABG pa-
rameters are shown in Table 1. Patients were divided
into two groups: standard therapy (NIV -) and standard
therapy plus NIV (NIV +).
Compared to NIV -, patients of NIV + had, in addition
to higher PaCO2 and lower values of pH and PaO2/FiO2,
increased heart rate, higher values of blood potassium,
bicarbonates and lactates and lower albumin and serum
chloride concentrations (Table 1).
NIV and ABG groups
The use of NIV support was lower in the patients be-
longing to group B (respiratory acidosis + metabolic al-
kalosis) than those belonging to group A (compensated
respiratory acidosis) and group C (respiratory acidosis +
metabolic acidosis, 25 %, vs 47 % and 96 % respectively;
p < 0.01) (Table 2).
Using a logistic regression model, we observed that
the probability of requiring NIV, in comparison to the
reference group B, was approximately 3 times higher in
patients of group A (OR 2.7; 95 % CI 1.04–6.82; p <0.05)
and 67 times higher in patients of group C (OR 67.1;
95 % CI 7.9–572.8; p < 0.001).
Electrolytes, edema and medications in the 3 groups
In a variance analysis, a statistically significant difference
in serum albumin concentrations was found in group C
(2.7 ± 0.11 g/dL) compared to group B (3.2 ± 0.09 g/dL;
p = 0.012) and group A (3.2 ± 0.07 g/dL; p = 0.003).
Significant hyperlactatemia (lactate values ≥ 2 mmol/L)
was found in all groups, even though in different per-
centages: in group B, patients with symptomatic
hyperlactatemia were all in conventional therapy (6/
20: 33 % of subjects in NIV- and no one in NIV +);
in the group A: 4/20 (25 %) in NIV - and 6/18
(33.3 %) in NIV +, and in the group C: 11/22 (50 %)
in NIV +, and no one in NIV -.
Table 1 Clinical and metabolic parameters (mean ± SD)
Variables NIV- (N = 55) NIV+ (N = 55) p
Age (years) 77.5 ± 8.8 77.6 ± 10.7 0.94
Gender (M/F) 29/26 28/27 0.85
Glucose (mg/dl) 142.3 ± 48.9 156.2 ± 76.5 0.26
Serum Uric Acid (mg/dl) 6.3 ± 2.0 6.6 ± 2.6 0.60
Serum Albumin (g/dl) 3.3 ± 0.5 2.9 ± 0.5 <0.001
C-Reactive-Protein (mg/l) 76.9 ± 75.7 27.4 ± 34.4 0.039
Serum Creatinine (mg/dl) 1.08 ± 0.58 1.29 ± 0.88 0.14
GFR (MDRD ml/min/1.73 m2) 71.8 ± 32.0 72.7 ± 49.3 0.91
HR (bpm) 83.8 ± 12.7 93.6 ± 13.6 <0.001
SBP (mmHg) 124.1 ± 17.0 120.0 ± 17.9 0.21
DBP (mmHg) 74.2 ± 9.9 72.5 ± 10.2 0.38
PaO2 (mmHg) 58.4 ± 13.5 60.2 ± 16.2 0.54
PaO2/FiO2 255.9 ± 38.6 200.2 ± 57.6 <0.001
pH 7.42 ± 0.05 7.29 ± 0.11 <0.001
PaCO2 (mmHg) 50.5 ± 5.5 75.5 ± 19.8 <0.001
Lactate (mmol/L) 1.38 ± 0.68 2.01 ± 1.76 0.017
Serum HCO3− (mmol/L) 32.6 ± 5.5 36.0 ± 10.1 0.036
Serum Na+ (mmol/L) 138.6 ± 3.9 139.1 ± 6.9 0.63
Serum K+ (mmol/L) 4.4 ± 0.6 4.7 ± 0.8 0.037
Serum Ca++ (mmol/L) 8.6 ± 0.6 8.4 ± 0.8 0.12
Serum Mg+ (mmol/L) 1.96 ± 0.32 1.89 ± 0.32 0.24
Serum Cl− (mmol/L) 99.4 ± 3.9 96.6 ± 8.1 0.030
GFR Glomerular Filtration Rate, MDRD Modification of Diet in Renal Disease
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The incidence of peripheral edema was not statistically
different between the 3 ABG groups: 25 % in group B,
26 % in group A, and 47 % in group C.
A statistically significant association was found be-
tween pCO2 values and serum chloride concentrations
both in the entire cohort and in the three separate
groups (Table 3).
Table 4 shows the list of medication taken for cardio-
vascular conditions.
Discussion
The hypercapnic AECOPD is an alarming event that re-
quires a careful management. Several factors determine
the final outcome in terms of both survival and need for
assisted mechanical ventilation in ICU. These factors
are patient’s age, general health status, disease sever-
ity, hemodynamic stability, concomitant comorbidities,
pulmonary function, respiratory acidosis degree, and
underlying AB and HE balance disorders [10].
This is a retrospective study, in which patients with
hypercapnic AECOPD, managed in an internal medicine
ward of a General Hospital have been studied. We have
shown that the group of patients with respiratory acid-
osis + metabolic acidosis (group C) had the most serious
prognosis, both in terms of non-invasive ventilation, and
ICU support. These patients often underestimate their
clinical status so that an acute event easily leads to
metabolic derangement, most of the times caused by
renal failure or worsening of diabetes mellitus. However,
in some patients, adequate medical treatment of the
metabolic imbalance, and the correction of hypoxemia
and hypercapnia by oxygen and NIV could allow a safe
management with quick recovery. In patients with hy-
percapnic AECOPD, a good metabolic compensation
and an adequate renal function significantly reduce the
mortality [11].
In respiratory acidosis, if an excessive increase of bi-
carbonate concentration (higher than expected by renal
compensation laws) occurs, a mixed disorder with au-
tonomous metabolic alkalosis should be suspected. In
patients with multiple comorbidities and multi-drug
treatment, several circumstances could lead to metabolic
Table 2 Non-Invasive-Ventilation (NIV +) in groups of patients according to ABG analysis values
Mixed respiratory acidosis – metabolic
alkalosis (N = 36)
Compensated respiratory
acidosis (N = 51)
Mixed respiratory - metabolic
acidosis (N = 23)
NIV - 75 % (27) 53 % (27) 4 % (1)
NIV + 25 % (9) 47 % (24) 96 % (22)
χ2 < 0.001
Table 3 Linear association among pCO2 and serum electrolytes in groups of patients according to ABG analysis values and in the
entire cohort
Variables Mixed respiratory acidosis –
metabolic alkalosis (N = 36)
Compensated respiratory
acidosis (N = 51)
Mixed respiratory - metabolic
acidosis (N = 23)
Hypercapnic COPD,
entire group (N = 110)
Na+ R2 0.10 0.01 0.16 0.002
Slope 0.67 1.06 −1.33 −0.02
p 0.06 0.03 0.06 0,62
K+ R2 0.001 −0.02 −0.001 0.003
Slope −1.53 −0.66 −8.08 1.45
p 0.58 0,84 0.33 0.58
HCO3
− R2 0.84 0.90 0.49 0.24
Slope 1.26 2.18 2.20 1.14
p 0.001 0.001 0.001 0.001
Cl− R2 0.30 0.32 0.21 0.20
Slope −1.28 −1.45 −1.24 −1.37
p 0.001 0.001 0.04 0.001
Anion Gap R2 0.20 0.11 0.08 0.04
Slope −0.71 −1.39 −0.82 −0.67
p 0.006 0.01 0.23 0.03
Lactate R2 0.10 0.02 0.01 0.01
Slope −5.54 −3.42 −0.95 1.58
p 0.06 0.30 0.65 0.25
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alkalosis. In our patients, the use of diuretics and ste-
roids and a relative reduction in circulating blood
volume were the main causes of metabolic alkalosis. We
observed that patient belonging to group B (respiratory
acidosis + metabolic alkalosis) had a better prognosis
than patients in group A (compensated respiratory acid-
osis) with a significantly lower need of NIV.
The admission to ICU was not significantly different
in comparison to patients belonging to group A.
These data are conflicting with Terzano et al. who ob-
served that metabolic alkalosis worsened the prognosis
of respiratory acidosis in hypercapnic AECOPD patients.
In their study, patients with mixed disorder (respiratory
acidosis plus metabolic alkalosis) had a longer and
higher incidence of NIV support than patients with com-
pensated respiratory acidosis [12].
To explain such different finding, we can speculate
that patients with hypercapnic AECOPD managed in an
Internal Medicine ward of a General Hospital are quite
different from patients managed in a Pulmonary Depart-
ment of a Teaching Hospital. The latter have scheduled
follow up visits and are hospitalized only when the
clinical status progressively deteriorates. In contrast,
hypercapnic AECOPD patients admitted to an Internal
Medicine ward of a General Hospital usually come from
the Emergency Department, where they are hospitalized
because their clinical status worsened for sudden events
(such as diarrhoea, vomiting, fever, sweating, decreased
fluid intake) with additional autonomous metabolic al-
kalosis. Therefore, a diuretic and/or glucocorticoid in-
duced metabolic alkalosis with hypovolemia is often
detectable in these patients. These events can be easily
managed by blood volume and serum chloride restoring
(with saline solution) allowing the clinical improvement
and avoiding the NIV support.
In an earlier study, it was shown that in COPD pa-
tients with peripheral edema treated with loop diuretics,
furosemide withdrawing led to increased ventilation and
an improvement in the respiratory acidosis [13].
Lactate concentration was higher in NIV+ group. Our
result confirms previous studies in which blood lactate
was considered a diagnostic hallmark of tissue hypoxia
and respiratory muscle fatigue and, indirectly, of COPD
severity in patients not requiring NIV [12]. However,
hyperlactataemia (lactate values > 2 mmol/L), plays a
different role in the three groups of AB disorders. In
fact, in group B it was present only in patients not re-
quiring NIV (33 %); in group A was present both in pa-
tients requiring (25 %) and not requiring NIV (30 %);
and in the group C it was present in 50 % of patients
requiring NIV. In group B the lactate overproduction
may reflect a positive response to the stress enabling an
alternative energetic way through a carbon units trans-
port between cells (“good lactate”); whereas in group C
the lactate hyperproduction is probably due to hypo-
perfusion (“bad lactate”) and should be immediately
recognized and treated [14, 15]. In the patients of the
NIV-treated respiratory acidosis group we didn’t ob-
serve metabolic “post-hypercapnic alcalosis” since the
concomitant metabolic component was simultaneously
treated and corrected.
We acknowledge that many of the cross-associations
between pCO2 and serum electrolytes found in our
study are expected, as the AB balance is closely related
to the HE balance. Nevertheless, some remarks seem
worthy of focus.
In Brackett’s classic experiment, on healthy volunteers,
acute hypercapnia was experimentally induced by having
them hyperventilating by breathing CO2–enriched (at
7 % and at 10 %) air. In these subjects, a variation of
both pH and bicarbonates occurred, with a very slight,
but significant, increase in Na+ and K+, and no changes
in Cl−, indeterminate anions (anion gap: AG) and lac-
tates concentrations [16]. In a following study with
patients with alveolar hypoventilation and absence of
clinical conditions potentially responsible for meta-
bolic alkalosis, the response to the chronic hypercap-
nia was investigated. In this group a decrease in pH
with a progressive increase in pCO2 was seen; more-
over, when pCO2 values increased, Cl
− decreased
whereas no significant association was found with HE
balance (Na+, K+ and AG) [17].
In our study population composed by patients with hy-
percapnic AECOPD, we found a significant association
Table 4 Cardiovascular drugs in groups of patients according to ABG analysis values and in the entire cohort
Mixed respiratory acidosis –
metabolic alkalosis (N = 36)
Compensated respiratory
acidosis (N = 51)
Mixed respiratory - metabolic
acidosis (N = 23)
Hypercapnic COPD,
entire cohort (N = 110)
Diuretics 33/36 40/51 22/23 95/110
ACE inhibitors 9/36 14/50 3/20 26/106
Angiotensin receptor antagonists 12/36 15/50 4/20 31/106
Calcium channel blocking agents 5/36 15/50 3/20 23/106
Beta-blockers 3/36 4/50 0/20 7/106
Nitroglycerin 7/36 3/50 1/20 11/106
Potassium sparing agents 4/36 3/50 1/21 8/107
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between increase in pCO2 and bicarbonate (which re-
flects the renal compensation) and a statistically signifi-
cant relationship between the pCO2 increase and serum
chloride decrease. Such associations were present in all
the subjects studied and was maintained also when
dividing the subjects in the 3 subgroups classified ac-
cording to the ABG disorder. Serum chloride decrease
may be related to bicarbonate increase as an attempt to
assure the electro-neutrality. We can interpret the data
of serum chloride reduction also in the light of the
Strong Ion Difference (SID) of Stewart’s theory (Stewart).
In this case, in hypercapnic AECOPD, after the pulmon-
ary response to increasing pCO2, the renal response
starts, by regulating Na+ and Cl−, which are the major
SID determinants. A relative (compared to Na+ concen-
tration) hypochloremia would lead to a SID increase and
would indicate a metabolic alkalosis with a bicarbonate
increase. According to this theory, therefore, bicarbonate
increase reflects a shift in bicarbonate equilibrium of the
ratio H+/ HCO3−connected with the SID variation [18].
In fact, in the overall group and in the subgroups with
compensated respiratory acidosis and respiratory acid-
osis + metabolic alkalosis, an inverse association between
pCO2 and indeterminate anions was found.
Conclusions
In conclusion our study, performed in a population of
inpatients admitted to an Internal Medicine Division for
hypercapnic AECOPD, shows that:
1. The AB balance and the HE balance, in agreement
with previous studies, are closely interconnected;
2. The electrolytic changes are usually in a range that
could be easily corrected with the conventional
pharmacological therapy;
3. In hypercapnic respiratory acidosis due to AECOPD,
differently from previous studies, the metabolic
alkalosis is not a negative prognostic factor neither
determines greater NIV support need;
4. The metabolic acidosis in addition to respiratory
acidosis is an unfavourable element, since it
determines an increased need of NIV and invasive
mechanical ventilation support.
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